Skip to main content
Download PDF

Correction to: Augmentation of tumor expression of HLADR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses

Journal of Translational Medicine volume 22, Article number: 836 (2024) Cite this article

The Original Article was published on 31 May 2024

Correction to: Journal of Translational Medicine (2022)22:524

https://doi.org/10.1186/s12967-024-05339-9

Following publication of the original article [1], we have been notified that there was a mistake in Copyright line.

It is now as follows: © The Author(s) 2024. Open Access. It should be as follows: This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2024.

The original article was updated.

References

  1. Larkin et al. Augmentation of tumor expression of HLADR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses. 2024;22:524 https://doi.org/10.1186/s12967-024-05339-9.

Download references

Author information

Authors and Affiliations

  1. Sinonasal and Skull Base Tumor Program, Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

    Riley M. Larkin, Diana C. Lopez & Nyall R. London Jr.

  2. University of Miami Miller School of Medicine, Miami, MD, USA

    Riley M. Larkin

  3. Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Diana C. Lopez, Gary L. Gallia & Nyall R. London Jr.

  4. Section on Translational Tumor Immunology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

    Yvette L. Robbins & Clint T. Allen

  5. Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

    Wiem Lassoued, Kenneth Canubas, James W. Hodge, Charalampos S. Floudas & James L. Gulley

  6. Molecular Histopathology Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA

    Andrew Warner, Baktiar Karim & Ksenia Vulikh

  7. Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Gary L. Gallia & Nyall R. London Jr.

Authors
  1. Riley M. Larkin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Diana C. Lopez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yvette L. Robbins
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wiem Lassoued
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kenneth Canubas
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Andrew Warner
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Baktiar Karim
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ksenia Vulikh
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. James W. Hodge
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Charalampos S. Floudas
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. James L. Gulley
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Gary L. Gallia
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Clint T. Allen
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Nyall R. London Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nyall R. London Jr..

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The online version of the original article can be found at https://doi.org/10.1186/s12967-024-05339-9.

The original version of this article was revised: It is now as follows: © The Author(s) 2024. Open Access. It should be as follows: This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2024.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Larkin, R.M., Lopez, D.C., Robbins, Y.L. et al. Correction to: Augmentation of tumor expression of HLADR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses. J Transl Med 22, 836 (2024). https://doi.org/10.1186/s12967-024-05514-y

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12967-024-05514-y

Journal of Translational Medicine

ISSN: 1479-5876

Contact us